Literature DB >> 24101488

Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects.

Sandrine Cestèle1, Emanuele Schiavon, Raffaella Rusconi, Silvana Franceschetti, Massimo Mantegazza.   

Abstract

Familial hemiplegic migraine (FHM) is a rare subtype of migraine with aura. Mutations causing FHM type 3 have been identified in SCN1A, the gene encoding the Nav1.1 Na(+) channel, which is also a major target of epileptogenic mutations and is particularly important for the excitability of GABAergic neurons. However, functional studies of NaV1.1 FHM mutations have generated controversial results. In particular, it has been shown that the NaV1.1-L1649Q mutant is nonfunctional when expressed in a human cell line because of impaired plasma membrane expression, similarly to NaV1.1 mutants that cause severe epilepsy, but we have observed gain-of-function effects for other NaV1.1 FHM mutants. Here we show that NaV1.1-L1649Q is nonfunctional because of folding defects that are rescuable by incubation at lower temperatures or coexpression of interacting proteins, and that a partial rescue is sufficient for inducing an overall gain of function because of the modifications in gating properties. Strikingly, when expressed in neurons, the mutant was partially rescued and was a constitutive gain of function. A computational model showed that 35% rescue can be sufficient for inducing gain of function. Interestingly, previously described folding-defective epileptogenic NaV1.1 mutants show loss of function also when rescued. Our results are consistent with gain of function as the functional effect of NaV1.1 FHM mutations and hyperexcitability of GABAergic neurons as the pathomechanism of FHM type 3.

Entities:  

Keywords:  Dravet syndrome; ankyrin; calmodulin; generalized epilepsy with febrile seizures plus; spreading depression

Mesh:

Substances:

Year:  2013        PMID: 24101488      PMCID: PMC3808640          DOI: 10.1073/pnas.1309827110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Sodium channel inactivation: molecular determinants and modulation.

Authors:  Werner Ulbricht
Journal:  Physiol Rev       Date:  2005-10       Impact factor: 37.312

Review 2.  Protein-protein interactions involving voltage-gated sodium channels: Post-translational regulation, intracellular trafficking and functional expression.

Authors:  Dongmin Shao; Kenji Okuse; Mustafa B A Djamgoz
Journal:  Int J Biochem Cell Biol       Date:  2009-02-02       Impact factor: 5.085

3.  Pure haploinsufficiency for Dravet syndrome Na(V)1.1 (SCN1A) sodium channel truncating mutations.

Authors:  Giulia Bechi; Paolo Scalmani; Emanuele Schiavon; Raffaella Rusconi; Silvana Franceschetti; Massimo Mantegazza
Journal:  Epilepsia       Date:  2011-12-09       Impact factor: 5.864

4.  Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.

Authors:  Frank H Yu; Massimo Mantegazza; Ruth E Westenbroek; Carol A Robbins; Franck Kalume; Kimberly A Burton; William J Spain; G Stanley McKnight; Todd Scheuer; William A Catterall
Journal:  Nat Neurosci       Date:  2006-08-20       Impact factor: 24.884

Review 5.  Navigating the channels and beyond: unravelling the genetics of the epilepsies.

Authors:  Ingo Helbig; Ingrid E Scheffer; John C Mulley; Samuel F Berkovic
Journal:  Lancet Neurol       Date:  2008-03       Impact factor: 44.182

6.  The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online.

Authors:  Kaate R J Vanmolkot; Elena Babini; Boukje de Vries; Anine H Stam; Tobias Freilinger; Gisela M Terwindt; Lisa Norris; Joost Haan; Rune R Frants; Nabih M Ramadan; Michel D Ferrari; Michael Pusch; Arn M J M van den Maagdenberg; Martin Dichgans
Journal:  Hum Mutat       Date:  2007-05       Impact factor: 4.878

Review 7.  Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine.

Authors:  Sandrine Cestèle; Angelo Labate; Raffaella Rusconi; Patrizia Tarantino; Laura Mumoli; Silvana Franceschetti; Grazia Annesi; Massimo Mantegazza; Antonio Gambardella
Journal:  Epilepsia       Date:  2013-02-08       Impact factor: 5.864

8.  An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability.

Authors:  Arthur J Barela; Salina P Waddy; Jay G Lickfett; Jessica Hunter; Aimee Anido; Sandra L Helmers; Alan L Goldin; Andrew Escayg
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

9.  Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures.

Authors:  Massimo Mantegazza; Antonio Gambardella; Raffaella Rusconi; Emanuele Schiavon; Ferdinanda Annesi; Rita Restano Cassulini; Angelo Labate; Sara Carrideo; Rosanna Chifari; Maria Paola Canevini; Raffaele Canger; Silvana Franceschetti; Grazia Annesi; Enzo Wanke; Aldo Quattrone
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

10.  Na Channel β Subunits: Overachievers of the Ion Channel Family.

Authors:  William J Brackenbury; Lori L Isom
Journal:  Front Pharmacol       Date:  2011-09-28       Impact factor: 5.810

View more
  34 in total

1.  Pharmacology of the Nav1.1 domain IV voltage sensor reveals coupling between inactivation gating processes.

Authors:  Jeremiah D Osteen; Kevin Sampson; Vivek Iyer; David Julius; Frank Bosmans
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

2.  Three epilepsy-associated GABRG2 missense mutations at the γ+/β- interface disrupt GABAA receptor assembly and trafficking by similar mechanisms but to different extents.

Authors:  Xuan Huang; Ciria C Hernandez; Ningning Hu; Robert L Macdonald
Journal:  Neurobiol Dis       Date:  2014-05-04       Impact factor: 5.996

3.  Modeling cortical spreading depression induced by the hyperactivity of interneurons.

Authors:  Mathieu Desroches; Olivier Faugeras; Martin Krupa; Massimo Mantegazza
Journal:  J Comput Neurosci       Date:  2019-10-17       Impact factor: 1.621

4.  Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy.

Authors:  Carolien G F de Kovel; Miriam H Meisler; Eva H Brilstra; Frederique M C van Berkestijn; Ruben van 't Slot; Stef van Lieshout; Isaac J Nijman; Janelle E O'Brien; Michael F Hammer; Mark Estacion; Stephen G Waxman; Sulayman D Dib-Hajj; Bobby P C Koeleman
Journal:  Epilepsy Res       Date:  2014-09-04       Impact factor: 3.045

5.  The safety dance: biophysics of membrane protein folding and misfolding in a cellular context.

Authors:  Jonathan P Schlebach; Charles R Sanders
Journal:  Q Rev Biophys       Date:  2014-11-25       Impact factor: 5.318

6.  Differential Inhibition of Neuronal Sodium Channel Subtypes by the General Anesthetic Isoflurane.

Authors:  Cheng Zhou; Kenneth W Johnson; Karl F Herold; Hugh C Hemmings
Journal:  J Pharmacol Exp Ther       Date:  2019-02-21       Impact factor: 4.030

7.  De novo mutations in HCN1 cause early infantile epileptic encephalopathy.

Authors:  Caroline Nava; Carine Dalle; Agnès Rastetter; Pasquale Striano; Carolien G F de Kovel; Rima Nabbout; Claude Cancès; Dorothée Ville; Eva H Brilstra; Giuseppe Gobbi; Emmanuel Raffo; Delphine Bouteiller; Yannick Marie; Oriane Trouillard; Angela Robbiano; Boris Keren; Dahbia Agher; Emmanuel Roze; Suzanne Lesage; Aude Nicolas; Alexis Brice; Michel Baulac; Cornelia Vogt; Nady El Hajj; Eberhard Schneider; Arvid Suls; Sarah Weckhuysen; Padhraig Gormley; Anna-Elina Lehesjoki; Peter De Jonghe; Ingo Helbig; Stéphanie Baulac; Federico Zara; Bobby P C Koeleman; Thomas Haaf; Eric LeGuern; Christel Depienne
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

8.  Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.

Authors:  Reesha R Patel; Cindy Barbosa; Tatiana Brustovetsky; Nickolay Brustovetsky; Theodore R Cummins
Journal:  Brain       Date:  2016-06-05       Impact factor: 13.501

9.  Influence of Pathogenic Mutations on the Energetics of Translocon-Mediated Bilayer Integration of Transmembrane Helices.

Authors:  Jonathan P Schlebach; Charles R Sanders
Journal:  J Membr Biol       Date:  2014-09-06       Impact factor: 1.843

Review 10.  Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models.

Authors:  Renzo Guerrini; Carla Marini; Massimo Mantegazza
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.